A detailed history of Aigh Capital Management LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Aigh Capital Management LLC holds 198,500 shares of ARDX stock, worth $1.17 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
198,500
Holding current value
$1.17 Million
% of portfolio
0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 31, 2025

BUY
$3.92 - $6.64 $778,120 - $1.32 Million
198,500 New
198,500 $1.1 Million
Q3 2022

Nov 10, 2022

SELL
$0.59 - $1.44 $1.35 Million - $3.29 Million
-2,285,945 Reduced 60.58%
1,487,476 $1.77 Million
Q2 2022

Aug 12, 2022

BUY
$0.51 - $1.17 $335,997 - $770,818
658,819 Added 21.15%
3,773,421 $2.23 Million
Q1 2022

May 12, 2022

BUY
$0.65 - $1.18 $463,316 - $841,098
712,795 Added 29.68%
3,114,602 $3.33 Million
Q4 2021

Feb 10, 2022

BUY
$0.86 - $1.7 $2.07 Million - $4.08 Million
2,401,807 New
2,401,807 $2.64 Million

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $908M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Aigh Capital Management LLC Portfolio

Follow Aigh Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aigh Capital Management LLC with notifications on news.